Cartesian Therapeutics (RNAC) Retained Earnings (2015 - 2026)
Cartesian Therapeutics (RNAC) reported Retained Earnings of -$4.6 million for Q1 2026, up 99.35% year-over-year from -$2.3 million in Q1 2025, and little changed quarter-over-quarter from -$4.6 million in Q4 2025.
Cartesian Therapeutics (RNAC) Retained Earnings (2015 - 2026) Analysis & Trends
Cartesian Therapeutics (RNAC) has 12 years of Retained Earnings data on file, last reported at -$4.6 million in Q1 2026.
- Retained Earnings for Q1 2026 came in at -$4.6 million, up 99.35% year-over-year; the trailing twelve-month figure through Mar 2026 was -$4.6 million (up 99.35% YoY), and the FY2025 annual result was -$4.6 million, up 99.34% from the prior year.
- Retained Earnings was little changed at -$4.6 million in Q1 2026 per RNAC's latest filing, from -$4.6 million in the prior quarter.
- Over five years, Retained Earnings peaked at -$4.5 million in Q2 2022 and troughed at -$709.8 million in Q1 2025.
- A 5-year average of -$250.9 million and a median of -$4.6 million in 2023 frame the typical range for Retained Earnings.
- The sharpest annual moves came in 2025 and 2026: Retained Earnings sank 15014.35% in 2025, then surged 99.35% in 2026.
- A 5-year view of Retained Earnings shows it stood at -$4.6 million in 2022, then tumbled by 13385.02% to -$614.6 million in 2023, then retreated by 12.6% to -$692.1 million in 2024, then jumped by 99.34% to -$4.6 million in 2025, then decreased by 0.15% to -$4.6 million in 2026.
- Business Quant data shows RNAC's Retained Earnings at -$4.6 million in Q1 2026, -$4.6 million in Q4 2025, and -$4.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | -153.89 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -211.85 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 130.89 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -279.00 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1.88 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 14.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -838.07 Mn |
| 10 | Cartesian Therapeutics | 261.84 Mn | 261.84 Mn | - | -4.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.58 Mn |
| Dec 31, 2025 | -4.58 Mn |
| Sep 30, 2025 | -4.59 Mn |
| Jun 30, 2025 | -693.90 Mn |
| Mar 31, 2025 | -709.80 Mn |
| Dec 31, 2024 | -692.07 Mn |
| Sep 30, 2024 | -4.61 Mn |
| Jun 30, 2024 | -4.59 Mn |
| Mar 31, 2024 | -671.47 Mn |
| Dec 31, 2023 | -614.65 Mn |
| Sep 30, 2023 | -436.99 Mn |
| Jun 30, 2023 | -4.60 Mn |
| Mar 31, 2023 | -4.57 Mn |
| Dec 31, 2022 | -4.56 Mn |
| Sep 30, 2022 | -4.53 Mn |
| Jun 30, 2022 | -4.48 Mn |
| Mar 31, 2022 | -401.54 Mn |
| Dec 31, 2021 | -430.32 Mn |
| Sep 30, 2021 | -442.60 Mn |
| Jun 30, 2021 | -4.56 Mn |